Skip to Content
Merck
All Photos(1)

Key Documents

T4376

Sigma-Aldrich

N-p-Tosyl-L-phenylalanine chloromethyl ketone

powder, ≥97% (TLC)

Synonym(s):

(S)-1-Chloro-3-tosylamido-4-phenyl-2-butanone, (S)-1-Chloro-4-phenyl-3-tosylamido-2-butanone, TPCK, Tosyl-L-phenylalanyl-chloromethane

Sign Into View Organizational & Contract Pricing


About This Item

Empirical Formula (Hill Notation):
C17H18ClNO3S
CAS Number:
Molecular Weight:
351.85
Beilstein:
2895215
EC Number:
MDL number:
UNSPSC Code:
12352202
PubChem Substance ID:
NACRES:
NA.77

product name

N-p-Tosyl-L-phenylalanine chloromethyl ketone, ≥97% (TLC), powder

biological source

synthetic

Assay

≥97% (TLC)

form

powder

potency

10-100 μM effective concentration

color

white

mp

106-108 °C (lit.)

solubility

DMSO: >10 mg/mL (stable for several months at 4°C.)
ethanol: 20 mg/mL

storage temp.

−20°C

SMILES string

Cc1ccc(cc1)S(=O)(=O)N[C@@H](Cc2ccccc2)C(=O)CCl

InChI

1S/C17H18ClNO3S/c1-13-7-9-15(10-8-13)23(21,22)19-16(17(20)12-18)11-14-5-3-2-4-6-14/h2-10,16,19H,11-12H2,1H3/t16-/m0/s1

InChI key

MQUQNUAYKLCRME-INIZCTEOSA-N

Looking for similar products? Visit Product Comparison Guide

General description

stable for several months at 4°C. Stock solutions (10 mM in methanol or ethanol) are stable for several months at 4°C.

Application

N-p-Tosyl-L-phenylalanine chloromethyl ketone has been used:
  • to investigate whether transcription factor NFκB is involved in renalase expression
  • to test the role of NF-κB activation
  • to study its inhibitory effect on chymotrypsin

Irreversible inhibitor of certain serine proteases; used to inhibit chymotrypsin in preparations of trypsin.

Biochem/physiol Actions

Blocks the LPS- or cytokine-induced activation of nuclear factor κB (NFκB), which, in turn, blocks the induction of iNOS and COX-2 transcription. Blocks activation of pp70s6k by all mitogens. Blocks apoptosis cell lines by inhibiting the processing of caspases in some cell lines and to some stimuli. Also blocks apoptosis initiated by Taxol (in MCF-7 human breast carcinoma cells).
N-p-Tosyl-L-phenylalanine chloromethyl ketone (TPCK) blocks the lipopolysaccharide (LPS)- or cytokine-induced activation of nuclear factor κB (NFκB), which, in turn, blocks the induction of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) transcription. Blocks activation of pp70s6k by all mitogens. Blocks apoptosis cell lines by inhibiting the processing of caspases in some cell lines and to some stimuli. Also blocks apoptosis initiated by Taxol (in MCF-7 human breast carcinoma cells). TPCK recognises the phenylalanine residue in chymotrypsin′s and prevents its function.

Packaging

Bottomless glass bottle. Contents are inside inserted fused cone.

Caution

Shelf-life is at least two years when stored desiccated at -20 °C.

Pictograms

CorrosionExclamation mark

Signal Word

Danger

Hazard Statements

Hazard Classifications

Eye Dam. 1 - Skin Irrit. 2 - STOT SE 3

Target Organs

Respiratory system

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Y Huang et al.
Oncogene, 18(23), 3431-3439 (1999-06-22)
The mechanism of Taxol-induced apoptosis was investigated in MCF-7 human breast carcinoma cells. Taxol-induced apoptosis was associated with phosphorylation of both c-Raf-1 and Bcl-2 and activation of ERK and JNK MAP kinases. The serine protease inhibitor N-tosyl-L-phenylalanine chloromethyl ketone (TPCK)
c-myc is required for osteoclast differentiation
Battaglin R, et al.
Journal of Bone and Mineral Research, 17(5), 763-773 (2002)
David Scheibner et al.
Scientific reports, 9(1), 11556-11556 (2019-08-11)
Avian influenza viruses (AIV) are classified into 16 hemagglutinin (HA; H1-H16) and 9 neuraminidase (NA; N1-N9) subtypes. All AIV are low pathogenic (LP) in birds, but subtypes H5 and H7 AIV can evolve into highly pathogenic (HP) forms. In the
Ling Xu et al.
Journal of pharmaceutical and biomedical analysis, 174, 441-449 (2019-06-21)
XMT-1522, an antibody-drug conjugate (ADC) currently in Phase I clinical development, represents the first Dolaflexin®-based, cleavable ADC with a high drug-antibody ratio (DAR). In this work, a novel immunocapture LC-MS/MS method was successfully developed for the simultaneous quantification of both
Christopher S Anderson et al.
Scientific reports, 7(1), 14614-14614 (2017-11-04)
The induction of antibodies specific for the influenza HA protein stalk domain is being pursued as a universal strategy against influenza virus infections. However, little work has been done looking at natural or induced antigenic variability in this domain and

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service